CAI
Caris Life Sciences, Inc.Healthcare · $8.7B market cap
Verdict
We can't put a fair value on CAI right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.
Business quality
1 of 5 clear the 10% bar. What are the Big Five?
Follow CAI
Track it on your watchlist and see the full analysis. Free.
Create a free accountInsider activity
Since Sep 3, 2026: no open-market purchases, 3 sales worth $14.8M and 2 other filings (stock awards, tax withholding and similar). Why purchases matter
Sales
Spetzler David Baxley
President · 2026-09-04
Sold
$3.0M
Spetzler David Baxley
President · 2026-09-03
Sold
$2.1M
Spetzler David Baxley
President · 2026-09-03
Sold
$9.7M
Other filings
About Caris Life Sciences, Inc.
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of…
Biotechnology
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works